DekaBank Deutsche Girozentrale - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 205 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$1,380,000
-38.7%
134,500
-17.6%
0.01%
-21.4%
Q4 2019$2,250,000
+61.2%
163,3000.0%0.01%
+55.6%
Q3 2019$1,396,000
-20.6%
163,3000.0%0.01%0.0%
Q2 2019$1,758,000
+299.5%
163,300
+611.3%
0.01%
+200.0%
Q1 2019$440,000
-49.9%
22,957
-74.4%
0.00%
-50.0%
Q4 2018$879,000
+99.8%
89,527
+290.0%
0.01%
+100.0%
Q3 2018$440,000
+17.0%
22,957
+15.7%
0.00%
+50.0%
Q2 2018$376,000
-58.7%
19,850
-66.8%
0.00%
-66.7%
Q1 2018$910,000
+3.5%
59,850
+1.6%
0.01%
-14.3%
Q4 2017$879,0000.0%58,9000.0%0.01%0.0%
Q3 2017$879,000
-18.4%
58,9000.0%0.01%
-22.2%
Q2 2017$1,077,000
+2.9%
58,9000.0%0.01%
-10.0%
Q1 2017$1,047,000
+7.7%
58,900
-7.8%
0.01%0.0%
Q4 2016$972,000
+6.8%
63,900
+8.1%
0.01%0.0%
Q3 2016$910,000
+18.6%
59,1000.0%0.01%
+11.1%
Q2 2016$767,000
+34.1%
59,100
+8.2%
0.01%
+28.6%
Q1 2016$572,000
-25.0%
54,600
-15.2%
0.01%
-22.2%
Q4 2015$763,000
+15.8%
64,400
+1.9%
0.01%
+12.5%
Q3 2015$659,000
-10.5%
63,200
+3.6%
0.01%
-11.1%
Q2 2015$736,000
-21.6%
61,000
+3.9%
0.01%
-25.0%
Q1 2015$939,000
-3.8%
58,700
-9.4%
0.01%0.0%
Q4 2014$976,000
+6.7%
64,800
-8.2%
0.01%0.0%
Q3 2014$915,000
-12.9%
70,600
+3.1%
0.01%
-25.0%
Q2 2014$1,050,000
+17.7%
68,500
-5.4%
0.02%
+14.3%
Q1 2014$892,000
+37.2%
72,400
+33.1%
0.01%
+27.3%
Q4 2013$650,000
+5.7%
54,400
+4.8%
0.01%0.0%
Q3 2013$615,00051,9000.01%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$157,835,70021.26%
AlphaCentric Advisors LLC 292,500$2,816,7751.60%
Quantedge Capital Pte Ltd 179,900$1,732,4370.94%
Intrinsic Value Partners, LLC 50,355$484,9190.62%
Brown Capital Management 3,719,796$35,821,6350.55%
ARMISTICE CAPITAL, LLC 3,456,000$33,281,2800.51%
SummerHaven Investment Management, LLC 67,765$652,5770.48%
BRAIDWELL LP 1,348,099$12,982,1930.41%
AFFINITY INVESTMENT ADVISORS, LLC 50,733$488,5590.32%
EMC Capital Management 43,315$4170.31%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders